Eyepoint Pharmaceuticals Stock Price History
| EYPT Stock | USD 9.23 0.28 3.13% |
Below is the normalized historical share price chart for Eyepoint Pharmaceuticals extending back to January 27, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eyepoint Pharmaceuticals stands at 9.23, as last reported on the 26th of November, with the highest price reaching 9.61 and the lowest price hitting 9.13 during the day.
If you're considering investing in Eyepoint Stock, it is important to understand the factors that can impact its price. Eyepoint Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Eyepoint Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0396, which denotes the company had a 0.0396% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Eyepoint Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Eyepoint Pharmaceuticals' Mean Deviation of 3.83, coefficient of variation of 3928.32, and Downside Deviation of 4.36 to check if our risk estimates are consistent with your expectations.
At this time, Eyepoint Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 372.9 M in 2024, whereas Capital Stock is likely to drop slightly above 39 K in 2024. . At this time, Eyepoint Pharmaceuticals' Price Earnings To Growth Ratio is comparatively stable compared to the past year. Price To Operating Cash Flows Ratio is likely to gain to 490.63 in 2024, whereas Price Book Value Ratio is likely to drop 3.13 in 2024. Eyepoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of January 2005 | 200 Day MA 13.454 | 50 Day MA 9.7686 | Beta 1.517 |
Eyepoint |
Sharpe Ratio = 0.0396
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EYPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.93 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Eyepoint Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eyepoint Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.7926 | Enterprise Value Ebitda (11.49) | Price Sales 13.3626 | Shares Float 47.6 M | Wall Street Target Price 33.4546 |
Eyepoint Pharmaceuticals Stock Price History Chart
There are several ways to analyze Eyepoint Stock price data. The simplest method is using a basic Eyepoint candlestick price chart, which shows Eyepoint Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 28, 2024 | 12.12 |
| Lowest Price | September 6, 2024 | 7.97 |
Eyepoint Pharmaceuticals November 26, 2024 Stock Price Synopsis
Various analyses of Eyepoint Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eyepoint Stock. It can be used to describe the percentage change in the price of Eyepoint Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eyepoint Stock.| Eyepoint Pharmaceuticals Accumulation Distribution | 35,369 | |
| Eyepoint Pharmaceuticals Price Rate Of Daily Change | 1.03 | |
| Eyepoint Pharmaceuticals Price Daily Balance Of Power | 0.58 |
Eyepoint Pharmaceuticals November 26, 2024 Stock Price Analysis
Eyepoint Stock Price History Data
The price series of Eyepoint Pharmaceuticals for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 4.15 with a coefficient of variation of 14.14. Under current investment horizon, the daily prices are spread out with arithmetic mean of 9.49. The median price for the last 90 days is 8.96. The company completed 1:10 stock split on 9th of December 2020. Eyepoint Pharmaceuticals completed dividends distribution on 2020-12-09.| Open | High | Low | Close | Volume | ||
| 11/25/2024 | 9.13 | 9.61 | 9.13 | 9.23 | 708,116 | |
| 11/22/2024 | 8.40 | 9.32 | 8.20 | 8.95 | 1,234,719 | |
| 11/21/2024 | 9.00 | 9.07 | 8.25 | 8.35 | 2,640,524 | |
| 11/20/2024 | 9.14 | 9.15 | 8.70 | 8.96 | 1,556,701 | |
| 11/19/2024 | 8.42 | 9.40 | 8.25 | 9.21 | 873,511 | |
| 11/18/2024 | 9.17 | 9.31 | 8.56 | 8.58 | 1,275,480 | |
| 11/15/2024 | 10.56 | 10.56 | 9.05 | 9.17 | 1,018,015 | |
| 11/14/2024 | 10.80 | 10.83 | 10.26 | 10.49 | 794,973 | |
| 11/13/2024 | 11.29 | 11.39 | 10.46 | 10.76 | 739,226 | |
| 11/12/2024 | 11.86 | 11.97 | 11.09 | 11.11 | 630,043 | |
| 11/11/2024 | 11.73 | 12.23 | 11.64 | 12.00 | 548,158 | |
| 11/08/2024 | 11.59 | 11.77 | 11.26 | 11.63 | 537,131 | |
| 11/07/2024 | 12.41 | 12.50 | 11.35 | 11.59 | 717,626 | |
| 11/06/2024 | 11.99 | 12.37 | 11.76 | 12.08 | 757,558 | |
| 11/05/2024 | 11.53 | 11.71 | 11.06 | 11.61 | 416,662 | |
| 11/04/2024 | 12.06 | 12.10 | 11.30 | 11.70 | 803,025 | |
| 11/01/2024 | 11.88 | 12.47 | 11.31 | 12.06 | 839,278 | |
| 10/31/2024 | 11.28 | 12.09 | 10.96 | 11.76 | 1,436,347 | |
| 10/30/2024 | 11.41 | 12.36 | 10.90 | 11.46 | 4,494,933 | |
| 10/29/2024 | 12.02 | 12.75 | 11.14 | 11.54 | 1,687,501 | |
| 10/28/2024 | 10.68 | 13.99 | 10.35 | 12.12 | 4,563,031 | |
| 10/25/2024 | 9.59 | 9.78 | 9.23 | 9.50 | 374,930 | |
| 10/24/2024 | 10.10 | 10.17 | 9.54 | 9.56 | 281,214 | |
| 10/23/2024 | 10.61 | 10.75 | 9.70 | 9.96 | 568,949 | |
| 10/22/2024 | 10.67 | 10.91 | 10.47 | 10.75 | 302,940 | |
| 10/21/2024 | 11.03 | 11.20 | 10.50 | 10.70 | 418,734 | |
| 10/18/2024 | 11.22 | 11.46 | 10.84 | 11.05 | 477,701 | |
| 10/17/2024 | 11.20 | 11.35 | 10.94 | 11.15 | 519,897 | |
| 10/16/2024 | 9.93 | 11.37 | 9.91 | 11.28 | 1,115,730 | |
| 10/15/2024 | 10.17 | 10.47 | 9.57 | 9.88 | 820,251 | |
| 10/14/2024 | 8.92 | 10.30 | 8.82 | 10.17 | 1,071,067 | |
| 10/11/2024 | 8.20 | 8.90 | 8.20 | 8.83 | 716,769 | |
| 10/10/2024 | 8.24 | 8.35 | 8.07 | 8.24 | 360,378 | |
| 10/09/2024 | 8.48 | 8.67 | 8.27 | 8.39 | 440,995 | |
| 10/08/2024 | 8.64 | 8.75 | 8.36 | 8.48 | 511,181 | |
| 10/07/2024 | 8.65 | 8.91 | 8.37 | 8.71 | 435,340 | |
| 10/04/2024 | 8.50 | 8.70 | 8.29 | 8.63 | 267,023 | |
| 10/03/2024 | 8.14 | 8.39 | 8.00 | 8.37 | 304,164 | |
| 10/02/2024 | 7.98 | 8.37 | 7.88 | 8.21 | 389,619 | |
| 10/01/2024 | 7.94 | 8.05 | 7.78 | 8.00 | 460,666 | |
| 09/30/2024 | 7.94 | 8.40 | 7.93 | 7.99 | 321,340 | |
| 09/27/2024 | 8.21 | 8.29 | 7.91 | 7.98 | 243,631 | |
| 09/26/2024 | 8.28 | 8.36 | 7.97 | 8.07 | 256,376 | |
| 09/25/2024 | 8.33 | 8.58 | 7.90 | 8.15 | 1,449,583 | |
| 09/24/2024 | 8.31 | 8.52 | 8.21 | 8.34 | 620,703 | |
| 09/23/2024 | 8.93 | 8.93 | 8.20 | 8.29 | 436,174 | |
| 09/20/2024 | 9.11 | 9.33 | 8.49 | 8.91 | 1,482,474 | |
| 09/19/2024 | 9.25 | 9.61 | 9.09 | 9.18 | 679,790 | |
| 09/18/2024 | 8.73 | 9.33 | 8.62 | 8.91 | 649,284 | |
| 09/17/2024 | 8.92 | 9.12 | 8.70 | 8.78 | 456,153 | |
| 09/16/2024 | 9.15 | 9.49 | 8.80 | 8.84 | 363,826 | |
| 09/13/2024 | 9.01 | 9.72 | 8.99 | 9.10 | 696,489 | |
| 09/12/2024 | 8.23 | 9.09 | 8.17 | 8.88 | 439,868 | |
| 09/11/2024 | 8.00 | 8.35 | 7.90 | 8.22 | 417,229 | |
| 09/10/2024 | 8.24 | 8.35 | 7.61 | 8.03 | 1,662,031 | |
| 09/09/2024 | 8.00 | 8.53 | 7.94 | 8.24 | 548,458 | |
| 09/06/2024 | 8.06 | 8.21 | 7.72 | 7.97 | 527,812 | |
| 09/05/2024 | 8.31 | 8.54 | 8.04 | 8.06 | 400,912 | |
| 09/04/2024 | 8.15 | 8.56 | 8.10 | 8.36 | 269,804 | |
| 09/03/2024 | 8.82 | 8.94 | 8.08 | 8.15 | 440,256 | |
| 08/30/2024 | 8.75 | 9.06 | 8.58 | 8.95 | 353,325 |
About Eyepoint Pharmaceuticals Stock history
Eyepoint Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eyepoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eyepoint Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eyepoint Pharmaceuticals stock prices may prove useful in developing a viable investing in Eyepoint Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.9 M | 40.8 M | |
| Net Loss | -92 M | -87.4 M |
Eyepoint Pharmaceuticals Quarterly Net Working Capital |
|
Eyepoint Pharmaceuticals Stock Technical Analysis
Eyepoint Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Eyepoint Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eyepoint Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eyepoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eyepoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0282 | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.0039 | |||
| Treynor Ratio | 0.0434 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.